Global Marijuana Market Could Reach $18.6 Billion by 2027: UN Report

Dec.12.2022
Global Marijuana Market Could Reach $18.6 Billion by 2027: UN Report
UNCTAD predicts the global cannabis market could reach $18.6 billion by 2027, if key issues are addressed.

According to a comprehensive industry report by the United Nations Conference on Trade and Development (UNCTAD), the global cannabis market could reach $18.6 billion by 2027 if countries around the world take action to clarify the legal status of marijuana and address other key issues.


According to a report from Hemp Today, citing data from Krungsri Research Intelligence, a research unit under the Bank of Ayudhya based in Bangkok, the market value of cannabis in the next five years could double the estimated $4.7 billion in 2020.


The report of the trade development conference covers:


Information: The authors of the report suggest that the cannabis industry needs increased transparency, including public data on all cannabis production outputs, specific country/region data, and pricing information. "At an international level, it is clear that the availability and accessibility of information needs to be improved. Efforts should be made to improve the current state of information on all aspects of this commodity.


The report suggests that other categories should be included, such as hemp seeds, hemp seed oil, hemp seed products, cannabis resin, and essential oils.


Sustainability: The report also indicates that environmental and social factors are "key to the success of any cannabis-related policy" and should therefore be considered within a broader legal and regulatory framework.


The report states that "to ensure the sustainable development of the global cannabis industry, cannabis cultivation can provide environmental benefits that can be taken into account in policies aimed at mitigating the impacts of climate change and restoring healthy ecosystems.


The report indicates that cannabis cultivation could potentially maximize land use and also increase income for farmers and rural communities, particularly in developing countries.


Industry Strategy: The Trade and Development Conference suggests that most regions of the world should consider a comprehensive cannabis cultivation strategy, stating that "given the relatively small size of the cannabis market and its inherent economic constraints, this approach is more viable." The document also notes that the comprehensive cultivation approach may lead to business opportunities in both primary and secondary markets, and that cannabis cultivation can further be monetized through the integration of voluntary carbon credit programs.


This 84-page report outlines the steps that the government can take to utilize the economic and social potential of marijuana, categorizes industrial hemp by output type, and demonstrates how the derivative products of this cannabis sub-industry are reflected in trade statistics.


According to the report, the cannabis value chain can promote growth in rural areas and contribute to manufacturing and food processing industries. However, in order to fully exploit this potential, countries may have to take specific actions. This represents the first international governmental organization document promoting the use of industrial hemp.


The report also addresses the legal issues surrounding marijuana. It notes that clarifying the legal status of marijuana as a non-narcotic substance is the first step the government should take in order to minimize legal and financial risks for producers.


The report suggests that all countries should permit the cultivation of non-intoxicating C. Sativa L. strains, despite the possibility of strict government control. Additionally, a method that promotes overall production and usage, rather than field THC thresholds, should be adopted for the benefit of the final product.


Alternatively, legislators could increase the THC threshold for "field" crops to the scientifically recognized non-toxic level. The report states, "This would increase the variety of strains available for use in the cannabis production chain, thus actually increasing the likelihood of cultivating strains that are best suited to specific environmental conditions and characteristics.


The report also suggests that additional production restrictions imposed by the regulatory framework must be identified and a regional cooperation strategy should be developed to establish a viable and sustainable value chain.


2FIRSTS will continue to follow and report on this topic, with future updates available on the "2FIRSTSAPP." Scan the QR code below to download the app.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

JUUL2 Sued Within a Week of FDA Authorization as AJ Marketing Alleges Infringement of Programmable Vape Patent
JUUL2 Sued Within a Week of FDA Authorization as AJ Marketing Alleges Infringement of Programmable Vape Patent
Less than a week after JUUL2 received U.S. FDA marketing authorization on August 28, 2026, JUUL Labs was sued for patent infringement in federal court in Delaware. AJ Marketing LLC filed the complaint on September 3, alleging that both JUUL 1 and JUUL2 infringe U.S. Patent No. 8,851,068 B2. The patent covers aspects of programmable electronic vaporization devices, including controls over dose delivery, usage frequency and operating parameters. The plaintiff is seeking reasonable royalties and ongoing royalties tied to the remaining life of the patent. JUUL has not yet publicly responded to the case.
Sep.10
U.S. House Defense Bill Includes Pilot Review of Vapes, Nicotine Pouches and Heated Tobacco for Military Smokers
U.S. House Defense Bill Includes Pilot Review of Vapes, Nicotine Pouches and Heated Tobacco for Military Smokers
On July 23, 2026, the U.S. House of Representatives passed its version of the Fiscal Year 2027 National Defense Authorization Act (NDAA), which includes Section 707 provisions requiring the Department of Defense to evaluate tobacco use and nicotine alternatives among military personnel. The pilot program would examine products including vapes, nicotine pouches and heated tobacco products, primarily among active-duty service members who continue using combustible tobacco. The provision is a policy evaluation effort, not an authorization for military vaping promotion or a ban on vape products.
Jul.28
Alaska Warns 1,500 Tobacco Retailers Over Unauthorized Vapes and Nicotine Pouches
Alaska Warns 1,500 Tobacco Retailers Over Unauthorized Vapes and Nicotine Pouches
Alaska Attorney General Stephen J. Cox has sent notices to more than 1,500 tobacco retailers and distributors warning them against selling vape and nicotine pouch products that lack authorization from the U.S. Food and Drug Administration (FDA). According to the Alaska Department of Law, businesses were advised to verify products against FDA authorization databases and avoid selling unauthorized nicotine products. The action highlights how state-level enforcement is increasingly extending federal product authorization requirements to retail channels.
Jul.24
R.J. Reynolds Vapor Company Launches Flavored Vuse Pro Pods in U.S. Without FDA Marketing Authorization
R.J. Reynolds Vapor Company Launches Flavored Vuse Pro Pods in U.S. Without FDA Marketing Authorization
R.J. Reynolds Vapor Company has begun selling four flavored Vuse Pro pods — Peach, Berry, Watermelon and Fresh Mint — in Ohio and selected other U.S. markets. According to the Vuse U.S. FAQ, Vuse Pro contains approximately 5.0% nicotine by weight, and Vuse Pro pre-filled pods are intended for use with Vuse Alto devices. Reynolds told 2Firsts that product labeling lists an e-liquid capacity of 2.0 mL per pod. The Vuse Alto Power Unit received FDA marketing authorization in 2024, while the new Vuse Pro pods themselves have not received marketing granted orders. The rollout follows the FDA’s May 2026 revision of enforcement priorities for certain unauthorized vaping products with qualifying pending applications.
BAT
Sep.10
As JUUL2 Wins FDA Authorization, Harm Reduction Journal Highlights the Role of Real-World Evidence in Nicotine Product Regulation
As JUUL2 Wins FDA Authorization, Harm Reduction Journal Highlights the Role of Real-World Evidence in Nicotine Product Regulation
A commentary published in the international open-access, peer-reviewed Harm Reduction Journal argues that randomized controlled trials remain central to evaluating smoking cessation efficacy but cannot alone capture real-world uptake, complete switching, longer-term use and population impact of non-combustible nicotine products such as e-cigarettes, heated tobacco and nicotine pouches. The authors frame impact as “reach × efficacy” and call for real-world evidence to complement RCTs. Three days after publication, the FDA authorized three JUUL2 products and highlighted complete switching among adult smokers in explaining its decision, providing a timely regulatory backdrop to the debate.
Sep.08
Spain Plans to Extend Smoking Ban to Terraces and Beaches, Bringing Vapes Under New Restrictions
Spain Plans to Extend Smoking Ban to Terraces and Beaches, Bringing Vapes Under New Restrictions
Spain is advancing a new tobacco-control reform that would expand smoking restrictions to additional public spaces, including restaurant terraces and beaches, while bringing vaping and other nicotine products into the same regulatory framework. The proposed measures aim to reduce secondhand smoke exposure, protect young people and expand smoke-free environments. The proposal remains under legislative development, and final implementation details have not yet been confirmed.
Jul.23